Literature DB >> 10782774

Correlation between choline level measured by proton MR spectroscopy and Ki-67 labeling index in gliomas.

H Shimizu1, T Kumabe, R Shirane, T Yoshimoto.   

Abstract

BACKGROUND AND
PURPOSE: The clinical relevance of proton MR spectroscopy needs further clarification as to its usefulness and limitations. The purpose of this study was to investigate the correlation between the semiquantitative choline-containing compound level (Cho value) measured by MR spectroscopy and the Ki-67 labeling index in gliomas.
METHODS: Localized proton spectra were obtained in 26 consecutive patients with glioma who subsequently underwent surgery for tumor removal. Metabolic values in the spectra were measured semiquantitatively using an external standard of reference. The Ki-67 labeling index was measured in the surgical specimen. Because the semiquantitative metabolic values may be affected by tissue components included in the spectroscopic voxel, the MR imaging appearance of the voxel within the tumor was classed as homogeneous or heterogeneous through visual evaluation of the presence of necrosis, cyst, hemorrhage, and calcification, and pattern of enhancement.
RESULTS: We found a strong linear correlation between the Cho value and the Ki-67 labeling index in the 18 homogeneous gliomas, but no correlation was found in the eight heterogeneous gliomas, which turned out to be malignant.
CONCLUSION: The semiquantitative Cho value is a reliable predictor of proliferative activity of gliomas when the tumor appears homogeneous on MR images.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10782774      PMCID: PMC7976633     

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  28 in total

1.  Metabolic imaging of patients with intracranial tumors: H-1 MR spectroscopic imaging and PET.

Authors:  P R Luyten; A J Marien; W Heindel; P H van Gerwen; K Herholz; J A den Hollander; G Friedmann; W D Heiss
Journal:  Radiology       Date:  1990-09       Impact factor: 11.105

2.  Thallium-201 single-photon emission computed tomographic and proton magnetic resonance spectroscopic characteristics of intracranial ganglioglioma: three technical case reports.

Authors:  T Kumabe; H Shimizu; Y Sonoda; R Shirane
Journal:  Neurosurgery       Date:  1999-07       Impact factor: 4.654

3.  In vivo proton MR spectroscopy of human gliomas: definition of metabolic coordinates for multi-dimensional classification.

Authors:  G Hagberg; A P Burlina; I Mader; W Roser; E W Radue; J Seelig
Journal:  Magn Reson Med       Date:  1995-08       Impact factor: 4.668

4.  Correlation between choline level and Gd-DTPA enhancement in patients with brain metastases of mammary carcinoma.

Authors:  P E Sijens; P van Dijk; M Oudkerk
Journal:  Magn Reson Med       Date:  1994-11       Impact factor: 4.668

5.  Comparative flow cytometric analysis of Ki-67 and proliferating cell nuclear antigen (PCNA) in solid neoplasms.

Authors:  K Steck; A K el-Naggar
Journal:  Cytometry       Date:  1994-11-01

Review 6.  In vivo magnetic resonance spectroscopy of human brain tumors.

Authors:  P B Barker; J D Glickson; R N Bryan
Journal:  Top Magn Reson Imaging       Date:  1993

7.  Positron emission tomography of fluorine-18-deoxyglucose and image-guided phosphorus-31 magnetic resonance spectroscopy in brain tumors.

Authors:  W D Heiss; W Heindel; K Herholz; J Rudolf; J Bunke; J Jeske; G Friedmann
Journal:  J Nucl Med       Date:  1990-03       Impact factor: 10.057

8.  Proton magnetic resonance spectroscopy in patients with glial tumors: a multicenter study.

Authors:  W G Negendank; R Sauter; T R Brown; J L Evelhoch; A Falini; E D Gotsis; A Heerschap; K Kamada; B C Lee; M M Mengeot; E Moser; K A Padavic-Shaller; J A Sanders; T A Spraggins; A E Stillman; B Terwey; T J Vogl; K Wicklow; R A Zimmerman
Journal:  J Neurosurg       Date:  1996-03       Impact factor: 5.115

9.  Noninvasive evaluation of malignancy of brain tumors with proton MR spectroscopy.

Authors:  H Shimizu; T Kumabe; T Tominaga; T Kayama; K Hara; Y Ono; K Sato; N Arai; S Fujiwara; T Yoshimoto
Journal:  AJNR Am J Neuroradiol       Date:  1996-04       Impact factor: 3.825

10.  Correlation between the bromodeoxyuridine labeling index and the MIB-1 and Ki-67 proliferating cell indices in cerebral gliomas.

Authors:  K Onda; R L Davis; M Shibuya; C B Wilson; T Hoshino
Journal:  Cancer       Date:  1994-10-01       Impact factor: 6.860

View more
  49 in total

1.  Tuning in on tumor activity with proton MR spectroscopy.

Authors:  L A Kwock
Journal:  AJNR Am J Neuroradiol       Date:  2001-05       Impact factor: 3.825

2.  An unusual intraventricular haemangiopericytoma: MRI and spectroscopy.

Authors:  E Hattingen; U Pilatus; C Good; K Franz; H Lanfermann; F E Zanella
Journal:  Neuroradiology       Date:  2003-04-18       Impact factor: 2.804

3.  The relationship between Cho/NAA and glioma metabolism: implementation for margin delineation of cerebral gliomas.

Authors:  Jun Guo; Chengjun Yao; Hong Chen; Dongxiao Zhuang; Weijun Tang; Guang Ren; Yin Wang; Jinsong Wu; Fengping Huang; Liangfu Zhou
Journal:  Acta Neurochir (Wien)       Date:  2012-06-23       Impact factor: 2.216

4.  Neuroimaging in pediatric brain tumors: Gd-DTPA-enhanced, hemodynamic, and diffusion MR imaging compared with MR spectroscopic imaging.

Authors:  A Aria Tzika; Maria K Zarifi; Liliana Goumnerova; Loukas G Astrakas; David Zurakowski; Tina Young-Poussaint; Douglas C Anthony; R Michael Scott; Peter McL Black
Journal:  AJNR Am J Neuroradiol       Date:  2002-02       Impact factor: 3.825

5.  Neurochemical correlates of caudate atrophy in Huntington's disease.

Authors:  Jeannie M Padowski; Kurt E Weaver; Todd L Richards; Mercy Y Laurino; Ali Samii; Elizabeth H Aylward; Kevin E Conley
Journal:  Mov Disord       Date:  2014-01-17       Impact factor: 10.338

Review 6.  Clinical Applications of Magnetic Resonance Spectroscopy in Brain Tumors: From Diagnosis to Treatment.

Authors:  Brent D Weinberg; Manohar Kuruva; Hyunsuk Shim; Mark E Mullins
Journal:  Radiol Clin North Am       Date:  2021-03-23       Impact factor: 2.303

7.  Evaluation of invasiveness of astrocytoma using 1H-magnetic resonance spectroscopy: correlation with expression of matrix metalloproteinase-2.

Authors:  Kai Zhang; Chuanfu Li; Ying Liu; Li Li; Xiangxing Ma; Xiangshui Meng; Dechao Feng
Journal:  Neuroradiology       Date:  2007-09-01       Impact factor: 2.804

8.  Relationship between choline and apparent diffusion coefficient in patients with gliomas.

Authors:  Inas S Khayal; Forrest W Crawford; Suja Saraswathy; Kathleen R Lamborn; Susan M Chang; Soonmee Cha; Tracy R McKnight; Sarah J Nelson
Journal:  J Magn Reson Imaging       Date:  2008-04       Impact factor: 4.813

9.  Proton magnetic resonance spectroscopy predicts proliferative activity in diffuse low-grade gliomas.

Authors:  Remy Guillevin; Carole Menuel; Hugues Duffau; Michel Kujas; Laurent Capelle; Agnès Aubert; Sophie Taillibert; Ahmed Idbaih; Joan Pallud; Giovanni Demarco; Robert Costalat; Khê Hoang-Xuan; Jacques Chiras; Jean-Noel Vallée
Journal:  J Neurooncol       Date:  2007-12-28       Impact factor: 4.130

10.  Metabolism of diffuse intrinsic brainstem gliomas in children.

Authors:  Ashok Panigrahy; Marvin D Nelson; Jonathan L Finlay; Richard Sposto; Mark D Krieger; Floyd H Gilles; Stefan Blüml
Journal:  Neuro Oncol       Date:  2007-11-14       Impact factor: 12.300

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.